par Rossi, J-F;van Hoof, Achiel;de Boeck, K;Johnson, S A;Bron, Dominique 
;Foussard, C;Lister, T A;Berthou, C;Kramer, M.;Littlewood, T J;Marcus, R E;Deconinck, E;Montillo, M;Guibon, O;Tollerfield, S M
Référence Journal of clinical oncology, 22, 7, page (1260-1267)
Publication Publié, 2004-04
;Foussard, C;Lister, T A;Berthou, C;Kramer, M.;Littlewood, T J;Marcus, R E;Deconinck, E;Montillo, M;Guibon, O;Tollerfield, S MRéférence Journal of clinical oncology, 22, 7, page (1260-1267)
Publication Publié, 2004-04
Article révisé par les pairs
| Titre: |
|
| Auteur: | Rossi, J-F; van Hoof, Achiel; de Boeck, K; Johnson, S A; Bron, Dominique; Foussard, C; Lister, T A; Berthou, C; Kramer, M.; Littlewood, T J; Marcus, R E; Deconinck, E; Montillo, M; Guibon, O; Tollerfield, S M |
| Informations sur la publication: | Journal of clinical oncology, 22, 7, page (1260-1267) |
| Statut de publication: | Publié, 2004-04 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Administration, Oral |
| Adult | |
| Aged | |
| Antimetabolites, Antineoplastic -- therapeutic use | |
| Female | |
| Humans | |
| Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Quality of Life | |
| Remission Induction | |
| Retrospective Studies | |
| Safety | |
| Survival Rate | |
| Treatment Outcome | |
| Vidarabine Phosphate -- analogs & derivatives | |
| Vidarabine Phosphate -- therapeutic use | |
| Note générale: | Clinical Trial |
| Clinical Trial, Phase II | |
| Comparative Study | |
| Journal Article | |
| Multicenter Study | |
| Research Support, Non-U.S. Gov't | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0732-183X |
| info:doi/10.1200/JCO.2004.05.012 | |
| info:pii/JCO.2004.05.012 | |
| info:pmid/15051774 |
